| CAS Number |
Product Names |
Molecular Formula |
|
1702936-92-2
|
Dabigatran Etexilate iMpurity H |
C19H20N4O3 |
|
1702816-75-8
|
PI3Kδ-IN-2 |
C28H37FN6O5S |
|
1702809-17-3
|
THZ-531 |
C30H32ClN7O2 |
|
1702311-34-9
|
Methanesulfonato{(R)-(-)-1-[(S)-2-(dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) |
C45H66FeNO3P2PdS 10*- |
|
1702300-72-8
|
tert-butyl 4-(3-chloropropyl)-4-cyanopiperidine-1-carboxylate |
C14H23ClN2O2 |
|
1702274-61-0
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
C20H25N5 |
|
1702260-52-3
|
4-(4-ethylpiperazin-1-yl)-2-nitroaniline |
C12H18N4O2 |
|
1702259-66-2
|
H3B-6527 |
C29H34Cl2N8O4 |
|
1701449-89-9
|
2-(3,4-Dichloro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
C13H17BCl2O3 |
|
1701435-39-3
|
2-Benzyloxy-4-(trifluoromethyl)phenylboronic acid |
C14H12BF3O3 |
|
1701434-52-7
|
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyrimidine |
C11H14BF3N2O2 |
|
1701405-00-6
|
1-[(4S)-4,5-Dihydro-4-isopropyl-2-oxazolyl]isoquinoline |
C15H16N2O |
|
1701403-10-2
|
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
C22H24Cl2N6O |
|
1700693-08-8
|
JH-II-127 |
C19H21ClN6O3 |
|
1700663-41-7
|
EPZ020411 |
C25H38N4O3 |
|
1700622-08-7
|
(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
C24H21ClFNO3 |
|
1700622-07-6
|
(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one |
C25H24FNO3 |
|
1700622-06-5
|
(3R,4S)-1-(3-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
C24H21F2NO3 |
|
1700611-18-2
|
1-Piperidinecarboxylic acid, 3-amino-4-fluoro-, 1,1-dimethylethyl ester, (3R,4S)- |
C10H19FN2O2 |
|
1699101-17-1
|
6-Isobutyl-4-methylpyridin-3-amine |
C10H16N2 |
|
1698890-39-9
|
3-Fluoro-4'-Methyl[1,1']biphenyl-4-yl-boronic acid |
C13H12BFO2 |
|
1698878-14-6
|
Nampt-IN-1 |
C20H25N3O5S |
|
1698653-24-5
|
Ethyl 4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrimidine-2-Carboxylate |
C9H13N3O2 |
|
1698055-86-5
|
ARS-1630 |
|
|
1698055-85-4
|
ARS-1620 |
|
|
1698027-18-7
|
7-bromo-6-chloro-8-fluoroquinazolin-4-ol |
C8H3BrClFN2O |
|
1698024-73-5
|
ARS-1323 |
C21H17ClF2N4O2 |
|
1696396-77-6
|
4-Bromo-spiro[9H-fluorene-9,8'-[8H]indolo[3,2,1-de]acridine] |
C31H18BrN |
|
1696392-12-7
|
Azilsartan Impurity |
|
|
1696392-11-6
|
1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid |
C24H21N3O4 |
|
1695920-54-7
|
2-Fluoro-4-methyl-5-nitro-benzonitrile |
C8H5FN2O2 |
|
1695537-84-8
|
3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole |
C27H19Br2N3O2 |
|
1695533-89-1
|
KO-947 |
|
|
1695529-70-4
|
Potassium (benzyloxycarbonylamino)methyltrifluoroborate |
C9H10BF3KNO2 |
|
1694731-93-5
|
Azido-PEG4-CH2CO2H |
C11H18O6 |
|
1694587-15-9
|
3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone |
C27H40O6 |
|
1693766-04-9
|
1-(1-(3-methoxyphenyl)-7-propoxyindolizin-3-yl)ethanone |
C20H21NO3 |
|
1693758-51-8
|
IPI-549 |
|
|
1693731-40-6
|
N-(5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)-2-methylphenyl)-2-(2-(pyrrolidin-1-yl)ethoxy)quinoline-6-carboxamide |
C32H32N4O5 |
|
1692906-03-8
|
Tert-Butyl (4-Bromo-5-Cyano-1-Methyl-1H-Pyrazol-3-Yl)(Methyl)Carbamate |
C11H15BrN4O2 |
|
1692906-02-7
|
Tert-Butyl (5-Cyano-1-Methyl-1H-Pyrazol-3-Yl)(Methyl)Carbamate |
C11H16N4O2 |
|
1691249-45-2
|
Zanubrutinib |
C27H29N5O3 |
|
1690341-57-1
|
3-Methyl-4-(4,4,5,5-Tetramethyl-[1,3,2]Dioxaborolan-2-Yl)-1-(2-Trimethylsilanyl-Ethoxymethyl)-1H-Pyrazole |
C16H31BN2O3Si |
|
1690331-06-6
|
2H-Quinolizine-3-carboxamide,N-{(2,4-difluorophenyl)methyl)-6,7,8,9-tetrahydro-1-hydroxy-7-methoxy-8-(2-methoxyethyl)-8-methyl-2,9-dioxo,(7r,8r)-Mix |
|
|
1689576-03-1
|
2-chloro-4-(biphenyl-3-yl)-6-phenyl-1,3,5-triazine |
C21H14ClN3 |
|
1689542-67-3
|
(S)-3-(4-(5-guanidinopentanamido)phenyl)-2-((S)-1-(phenylsulfonyl)pyrrolidine-2-carboxamido)propanoic acid hydrochloride |
C26H35ClN6O6S |
|
1689538-58-6
|
4-(biphenyl-4-yl)-6-chloro-2-phenylpyrimidine |
C22H15ClN2 |
|
1689509-92-9
|
2-Methyl-4-(trifluoromethyl)phenylboronic acid pinacol ester |
C14H20BF3O3 |
|
1688666-41-2
|
Triethylene glycol 4-methylbenzyl ether tosylate |
C21H28O6S |
|
1688666-37-6
|
Tetraethylene glycol 4- tertbutyl benzyl ether tosylate |
C26H38O7S |
|
1688666-28-5
|
Tetraethylene glycol 4-methylbenzyl ether tosylate |
C23H32O7S |
|
1688656-72-5
|
1,1,4,4,6-Pentamethyl-7-(1-(p-tolyl)vinyl)-1,2,3,4-tetrahydronaphthalene |
C24H30 |
|
1688656-71-4
|
2-(4-Chloropyridin-2-yl)acetic acid hydrochloride |
C7H7Cl2NO2 |
|
1688656-70-3
|
Bis((2-bromopyridin-4-yl)methyl)amine |
C12H11Br2N3 |
|
1688656-69-0
|
Ethyl 4-ethoxyquinoline-7-carboxylate |
C14H15NO3 |
|
1687855-43-1
|
methyl4-aminoisoquinoline-8-carboxylate |
C11H10N2O2 |
|
1687736-54-4
|
SGC707 |
C16H18N4O2 |
|
1686149-74-5
|
BMS-589154) |
C26H27N5O4 |
|
1686128-01-7
|
1-(4-METHOXYPHENYL)-1-ETHANONE N-[4-(4-CHLOROPHENYL)-1,3-THIAZOL-2-YL]HYDRAZONE |
C18H16ClN3OS |
|
1686108-69-9
|
3-bromo-7,8-difluoroquinoline |
C9H4BrF2N |
|
1686102-84-0
|
(4-(4-(2,2,2-trifluoroethyl)phenoxy)phenyl)methanol |
C15H13F3O2 |
|
1686100-04-8
|
Boronic acid, B-(9-[1,1'-biphenyl]-4-yl-9H-carbazol-2-yl)- |
C24H18BNO2 |
|
1684452-85-4
|
Mirabegron Impurity 11 |
C21H24N4O2S |
|
1684452-83-2
|
Mirabegron Impurity |
C26H28N6O3S2 |
|
1684433-60-0
|
1-Boc-3-trifluoromethylpyrazole-5-boronic acid |
C9H12BF3N2O4 |
|
1684427-19-7
|
2-(7-Fluoro-2H-1,3-benzodioxol-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
C13H16BFO4 |
|
1682655-57-7
|
trans-3-Methyl-4-aMinotetrahydropyran hydrochloride |
C6H14ClNO |
|
1682653-80-0
|
Tetrazine-PEG5-NHS ester |
C27H36N6O10 |
|
1680184-59-1
|
Afatinib iMpurity |
|
|
1679342-26-7
|
(2Z)-6-hydroxy-2-(pyridin-4-ylmethylidene)-1-benzofuran-3(2H)-one |
C14H9NO3 |
|
1678534-30-9
|
(1-cyclopropyl-1H-pyrazol-4-yl)boronic acid |
C6H9BN2O2 |
|
1678527-98-4
|
tert-butyl N-(3-ethynyloxetan-3-yl)carbamate |
C10H15NO3 |
|
1678511-52-8
|
14H-Benzo[c]benzofuro[2,3-a]carbazole |
C22H13NO |
|
1677681-05-8
|
1-Benzo[b]thien-4-yl-piperazine dihydrochloride |
C12H16Cl2N2S |
|
1677677-90-5
|
2-(3-chlorophenyl)dibenzo[f,h]quinoxaline |
C22H13ClN2 |
|
1676893-24-5
|
NSC781406 |
C29H27F2N5O5S2 |
|
1676104-73-6
|
Fmoc-Thr(tBu)-Thr(Psi(Me,Me)pro)-OH |
C30H38N2O7 |
|
1675248-19-7
|
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide |
C16H22N6O2 |
|
1675248-18-6
|
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- |
|
|
1675238-75-1
|
1675238-75-1 |
C42H44ClN2+ |
|
1675221-59-6
|
Azilsartan Impurity |
|
|
1675203-84-5
|
PD-L1 inhibitor 1 |
C25H29N3O3 |
|
1675201-83-8
|
2-Piperidinecarboxylic acid, 1-[[2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-, (2S)- |
C29H33NO5 |
|
1675201-14-5
|
Sitagliptin IMpurity |
|
|
1674398-09-4
|
tert-butyl2-(4-(benzyloxy)-1-ethoxy-1,3-dioxobutan-2-ylidene)hydrazine-1-carboxylate |
C18H24N2O6 |
|
1674390-16-9
|
(3-bromo-1H-1,2,4-triazol-1-yl)methanol |
C3H4BrN3O |
|
1674390-12-5
|
3,5-dibromo-1-(chloromethyl)-1H-1,2,4-triazole |
C3H2Br2ClN3 |
|
1674390-11-4
|
2-bromo-7,8-dihydro[1,2,4]triazolo[5,1-b][1,5,3]dioxazepine |
C5H6BrN3O2 |
|
1674390-10-3
|
[3-bromo-5-(dimethylamino)-1H-1,2,4-triazol-1-yl]acetic acid |
C6H9BrN4O2 |
|
1674390-09-0
|
(3-bromo-5-methoxy-1H-1,2,4-triazol-1-yl)acetic acid |
C5H6BrN3O3 |
|
1674390-06-7
|
1-(3-bromo-1H-1,2,4-triazol-5-yl)piperazine hydrobromide |
C6H11Br2N5 |
|
1674390-03-4
|
(4-Acetylamino-1-amino-cyclohexyl)-acetic acid |
C10H18N2O3 |
|
1674389-99-1
|
3-bromo-1-(chloromethyl)-1H-1,2,4-triazole |
C3H3BrClN3 |
|
1674389-91-3
|
3-bromo-1-(methoxymethyl)-1H-1,2,4-triazole-5-carboxamide |
C5H7BrN4O2 |
|
1674389-82-2
|
methyl (3-bromo-5-hydroxy-1H-1,2,4-triazol-1-yl)acetate |
C5H6BrN3O3 |
|
1674389-79-7
|
(3,5-dibromo-1H-1,2,4-triazol-1-yl)methanol |
C3H3Br2N3O |
|
1674386-82-3
|
Lipoamido-PEG2-alcohol |
C14H27NO4S2 |
|
1674334-59-8
|
3-Bromo-11,11-dimethyl-11H-benzo[b]fluorene |
C19H15Br |
|
1673546-62-7
|
Linagliptin Impurity F |
C27H27F3N8O3 |
|
1672665-49-4
|
PT-2385 |
C17H12F3NO4S |
